264 related articles for article (PubMed ID: 33407820)
1. Fluralaner as a novel treatment for sarcoptic mange in the bare-nosed wombat (Vombatus ursinus): safety, pharmacokinetics, efficacy and practicable use.
Wilkinson V; Takano K; Nichols D; Martin A; Holme R; Phalen D; Mounsey K; Charleston M; Kreiss A; Pye R; Browne E; Næsborg-Nielsen C; Richards SA; Carver S
Parasit Vectors; 2021 Jan; 14(1):18. PubMed ID: 33407820
[TBL] [Abstract][Full Text] [Related]
2. The use of Cydectin® by wildlife carers to treat sarcoptic mange in free-ranging bare-nosed wombats (Vombatus ursinus).
Old JM; Skelton CJA; Stannard HJ
Parasitol Res; 2021 Mar; 120(3):1077-1090. PubMed ID: 33438043
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of orally and topically administered fluralaner (Bravecto
Chiummo R; Petersen I; Plehn C; Zschiesche E; Roepke R; Thomas E
Parasit Vectors; 2020 Oct; 13(1):524. PubMed ID: 33069261
[TBL] [Abstract][Full Text] [Related]
4. Sarcoptic mange changes bacterial and fungal microbiota of bare-nosed wombats (Vombatus ursinus).
Næsborg-Nielsen C; Eisenhofer R; Fraser TA; Wilkinson V; Burridge CP; Carver S
Parasit Vectors; 2022 Sep; 15(1):323. PubMed ID: 36100860
[TBL] [Abstract][Full Text] [Related]
5. Current distribution of sarcoptic mange in wombats.
Martin RW; Handasyde KA; Skerratt LF
Aust Vet J; 1998 Jun; 76(6):411-4. PubMed ID: 9673766
[TBL] [Abstract][Full Text] [Related]
6. Morphological identification of ticks and molecular detection of tick-borne pathogens from bare-nosed wombats (Vombatus ursinus).
Beard D; Stannard HJ; Old JM
Parasit Vectors; 2021 Jan; 14(1):60. PubMed ID: 33468211
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and pharmacodynamic considerations for treating sarcoptic mange with cross-relevance to Australian wildlife.
Takano K; de Hayr L; Carver S; Harvey RJ; Mounsey KE
Int J Parasitol Drugs Drug Resist; 2023 Apr; 21():97-113. PubMed ID: 36906936
[TBL] [Abstract][Full Text] [Related]
8. Sarcoptic mange in wombats-A review and future research directions.
Old JM; Sengupta C; Narayan E; Wolfenden J
Transbound Emerg Dis; 2018 Apr; 65(2):399-407. PubMed ID: 29150905
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of fluralaner administered either orally or topically for the treatment of naturally acquired Sarcoptes scabiei var. canis infestation in dogs.
Taenzler J; Liebenberg J; Roepke RK; Frénais R; Heckeroth AR
Parasit Vectors; 2016 Jul; 9(1):392. PubMed ID: 27387742
[TBL] [Abstract][Full Text] [Related]
10. Host, environment, and anthropogenic factors drive landscape dynamics of an environmentally transmitted pathogen: Sarcoptic mange in the bare-nosed wombat.
Ringwaldt EM; Brook BW; Buettel JC; Cunningham CX; Fuller C; Gardiner R; Hamer R; Jones M; Martin AM; Carver S
J Anim Ecol; 2023 Sep; 92(9):1786-1801. PubMed ID: 37221666
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy of orally administered fluralaner for treatment of scabies in six free-ranging raccoon dogs (Nyctereutes procyonoides).
Hyun JE; Jang HK; Hwang CY; Yeon SC
Vet Dermatol; 2019 Jun; 30(3):267-e81. PubMed ID: 30895701
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a spot-on combination of fluralaner plus moxidectin against naturally acquired Sarcoptes scabiei infestation in 10 pet rabbits: Retrospective case series.
d'Ovidio D; Santoro D
Vet Dermatol; 2023 Feb; 34(1):3-6. PubMed ID: 36062517
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of a novel oral isoxazoline, sarolaner (Simparica™), for the treatment of sarcoptic mange in dogs.
Becskei C; De Bock F; Illambas J; Cherni JA; Fourie JJ; Lane M; Mahabir SP; Six RH
Vet Parasitol; 2016 May; 222():56-61. PubMed ID: 26928658
[TBL] [Abstract][Full Text] [Related]
14. Sarcoptes scabiei: The Mange Mite with Mighty Effects on the Common Wombat (Vombatus ursinus).
Simpson K; Johnson CN; Carver S
PLoS One; 2016; 11(3):e0149749. PubMed ID: 26943790
[TBL] [Abstract][Full Text] [Related]
15. Correction to: Fluralaner as a novel treatment for sarcoptic mange in the bare-nosed wombat (Vombatus ursinus): safety, pharmacokinetics, efficacy and practicable use.
Wilkinson V; Takano K; Nichols D; Martin A; Holme R; Phalen D; Mounsey K; Charleston M; Kreiss A; Pye R; Browne E; Næsborg-Nielsen C; Richards SA; Carver S
Parasit Vectors; 2021 Mar; 14(1):140. PubMed ID: 33673849
[No Abstract] [Full Text] [Related]
16. Efficacy of fluralaner in 17 dogs with sarcoptic mange.
Romero C; Heredia R; Pineda J; Serrano JA; Mendoza GD; Trápala P; Cordero AM
Vet Dermatol; 2016 Oct; 27(5):353-e88. PubMed ID: 27511592
[TBL] [Abstract][Full Text] [Related]
17. Clinical response of captive common wombats (Vombatus ursinus) infected with Sarcoptes scabiei var. wombati.
Skerratt LF
J Wildl Dis; 2003 Jan; 39(1):179-92. PubMed ID: 12685082
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of moxidectin in the southern hairy-nosed wombat (Lasiorhinus latifrons).
Death CE; Taggart DA; Williams DB; Milne R; Schultz DJ; Holyoake C; Warren KS
J Wildl Dis; 2011 Jul; 47(3):643-9. PubMed ID: 21719829
[TBL] [Abstract][Full Text] [Related]
19. A model for the treatment of environmentally transmitted sarcoptic mange in bare-nosed wombats (Vombatus ursinus).
Beeton NJ; Carver S; Forbes LK
J Theor Biol; 2019 Feb; 462():466-474. PubMed ID: 30502410
[TBL] [Abstract][Full Text] [Related]
20. Field effectiveness and safety of fluralaner plus moxidectin (Bravecto® Plus) against ticks and fleas: a European randomized, blinded, multicenter field study in naturally-infested client-owned cats.
Rohdich N; Zschiesche E; Wolf O; Loehlein W; Pobel T; Gil MJ; Roepke RKA
Parasit Vectors; 2018 Nov; 11(1):598. PubMed ID: 30454052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
